IL6 and Miyoshi myopathy: Finally, it is noteworthy that similar events were also observed in MM cells highly resistant to the proteasome inhibitor bortezomib [16], as well as in IL-6-stimulated cells (OPM2) cultured in the presence of this cytokine or stromal cell conditioned medium.